Advanced Search

Study Preview



Study Title and Description

Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma



Key Questions Addressed
1 Key Question
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma
Author Diana M. Sobieraj, Pharm.D.; William L. Baker, Pharm.D.; Erin R. Weeda, Pharm.D.; Elaine Nguyen, Pharm.D.; M.P.H. Craig I. Coleman, Pharm.D.; C. Michael White, Pharm.D.; Stephen C. Lazarus, M.D.; Kathryn V. Blake, Pharm.D.; Jason E. Lang, M.D., M.P.H.
Country University of Connecticut Evidence-based Practice Center
Year 2018
Numbers

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Extraction Form
Design Details
Question... Follow Up Answer Follow-up Answer
What is the PRIMARY FOCUS of the systematic review? Therapeutics
  • Comments Comments (
    0
    ) |
What is the DISCIPLINE within which the systematic review topic falls? Medicine
  • Comments Comments (
    0
    ) |
What was the primary HEALTH AREA addressed in the systematic review? Diseases of the respiratory system
  • Comments Comments (
    0
    ) |
Was the country of origin of the systematic review reported? ... Yes, the country was... ... United States
  • Comments Comments (
    0
    ) |
Is this review conducted as part of the Agency for Healthcare Research and Quality (AHRQ) Evidence-based Practice Center (EPC) Program? Yes
  • Comments Comments (
    0
    ) |
Is the systematic review registered on PROSPERO? ... Yes, and the PROSPERO ID is .... ... CRD42016047985
  • Comments Comments (
    0
    ) |
What were the reported sources of FUNDING for the systematic review? Yes
  • Comments Comments (
    0
    ) |
No
  • Comments Comments (
    0
    ) |
No
  • Comments Comments (
    0
    ) |
No
  • Comments Comments (
    0
    ) |
No
  • Comments Comments (
    0
    ) |
No
  • Comments Comments (
    0
    ) |
Were sources of FUNDING for the systematic review reported in the journal publication? Yes, reported funding source for the review
  • Comments Comments (
    0
    ) |
How many Key Questions were included in this review? 6
  • Comments Comments (
    0
    ) |
How many studies were included in this review? 74
  • Comments Comments (
    0
    ) |
What was/were the funding source(s)? AHRQ (Contract No. 290-2015-00012-I)
  • Comments Comments (
    0
    ) |
If this was not a full systematic review, what was it?
  • Comments Comments (
    0
    ) |
What is the name of the project on the SRDR Published Projects page? Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma
  • Comments Comments (
    0
    ) |
What year was the project last updated in SRDR? 2019
  • Comments Comments (
    0
    ) |
Is this a Cochrane review? No
  • Comments Comments (
    0
    ) |
What was the format of addition of data to SRDR? Upload
  • Comments Comments (
    0
    ) |
Upload
  • Comments Comments (
    0
    ) |
Upload
  • Comments Comments (
    0
    ) |
What year was the project published to SRDR? 2019
  • Comments Comments (
    0
    ) |
What month was the project published to SRDR? July
  • Comments Comments (
    0
    ) |
What month was the project created in SRDR? May
  • Comments Comments (
    0
    ) |
What year was the project created in SRDR? 2019
  • Comments Comments (
    0
    ) |
What was the duration in months from project creation to publication in SRDR? 2
  • Comments Comments (
    0
    ) |
What was the name of the EPC or Cochrane Review Group conducting the project? University of Connecticut Evidence-based Practice Center
  • Comments Comments (
    0
    ) |
What is the DOI of the project? 10.26300/0tvg-3a21
  • Comments Comments (
    0
    ) |




Results & Comparisons

No Results found.